STAND. COM. REP. NO. 1582

 

Honolulu, Hawaii

, 2019

 

RE: S.B. No. 807

S.D. 1

H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

 

Sir:

 

Your Committees on Judiciary and Consumer Protection & Commerce, to which was referred S.B. No. 807, S.D. 1, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

 

beg leave to report as follows:

 

The purpose of this measure is to specify that health care providers shall not be required to consult the electronic prescription accountability system before prescribing controlled substances:

 

(1) That will be administered directly to hospital inpatients under the supervision of a health care provider licensed to practice within the State;

 

(2) For an initial prescription for a patient being treated for post-operative pain, provided the prescription is limited to a three-day supply; and

 

(3) For patients with a terminal disease receiving hospice or other types of palliative care.

 

The Department of Health, Department of Public Safety, Hawaii Health Systems Corporation, Healthcare Association of Hawaii, Kaiser Permanente Hawaii, The Queen's Health Systems, and Hawaii Pacific Health testified in support of this measure.

 

As affirmed by the records of votes of the members of your Committees on Judiciary and Consumer Protection & Commerce that are attached to this report, your Committees are in accord with the intent and purpose of S.B. No. 807, S.D. 1, H.D. 1, and recommend that it be referred to your Committee on Finance.

 

 

Respectfully submitted on behalf of the members of the Committees on Judiciary and Consumer Protection & Commerce,

 

 

____________________________

ROY M. TAKUMI, Chair

 

____________________________

CHRIS LEE, Chair